The LR3 modification has been shown in animal and in vitro models to exhibit greater potency and a longer duration of activity compared to native IGF-1
Related support groups Ozempic (121 questions, 241 members) Wegovy (52 questions, 129 members) Zepbound (32 questions, 51 members) Saxenda (63 questions, 383 members) Mounjaro (60 questions, 153 members) Victoza (54 questions, 304 members) Semaglutide (45 questions, 57 members) Trulicity (34 questions, 184 members) Rybelsus (22 questions, 33 members) Tirzepatide (19 questions, 20 members) Liraglutide (17 questions, 47 members)
Table of Contents show Key Takeaways Most elective IV providers set a minimum age of 18
Ozempic, which is also called semaglutide, acts on the GLP-1 receptor